西那西呱

化合物

西那西呱INN:cinaciguat;开发代号:BAY 58-2667)是一种实验性可溶性鸟苷酸环化酶英语Soluble guanylyl cyclase激活剂,设计用于治疗急性失代偿性心力衰竭英语Acute decompensated heart failure[1][2]该药物能提高环磷酸鸟苷的产量进而引起肺血管舒张[3][4]

西那西呱
临床资料
给药途径静脉注射 (?)
ATC码
  • 未分配
识别信息
  • 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)
    phenyl]methoxy}phenyl)ethyl]amino}methyl)
    benzoic acid
CAS号329773-35-5  checkY
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C36H39NO5
摩尔质量565.71 g·mol−1
3D模型(JSmol英语JSmol
  • c4ccccc4CCc3ccc(cc3)COc1ccccc1CCN(CCCCC(O)=O)Cc2ccc(C(=O)O)cc2
  • InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41) ☒N
  • Key:WPYWMXNXEZFMAK-UHFFFAOYSA-N ☒N

参考资料

编辑
  1. ^ Gheorghiade, Mihai; Greene, Stephen J.; Filippatos, Gerasimos; Erdmann, Erland; Ferrari, Roberto; Levy, Phillip D.; Maggioni, Aldo; Nowack, Christina; Mebazaa, Alexandre; COMPOSE Investigators and Coordinators. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. European Journal of Heart Failure. 2012-09, 14 (9) [2024-06-02]. ISSN 1879-0844. PMID 22713287. doi:10.1093/eurjhf/hfs093. (原始内容存档于2024-06-02). 
  2. ^ Erdmann, Erland; Semigran, Marc J.; Nieminen, Markku S.; Gheorghiade, Mihai; Agrawal, Rahul; Mitrovic, Veselin; Mebazaa, Alexandre. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. European Heart Journal. 2013-01, 34 (1) [2024-06-02]. ISSN 1522-9645. PMID 22778174. doi:10.1093/eurheartj/ehs196. (原始内容存档于2024-06-02). 
  3. ^ Chester, Marc; Seedorf, Gregory; Tourneux, Pierre; Gien, Jason; Tseng, Nancy; Grover, Theresa; Wright, Jason; Stasch, Johannes-Peter; Abman, Steven H. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2011-11, 301 (5) [2024-06-02]. ISSN 1522-1504. PMC 3213988 . PMID 21856817. doi:10.1152/ajplung.00138.2010. (原始内容存档于2024-08-12). 
  4. ^ Chester, Marc; Tourneux, Pierre; Seedorf, Greg; Grover, Theresa R.; Gien, Jason; Abman, Steven H. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2009-08, 297 (2) [2024-06-02]. ISSN 1522-1504. PMC 2742799 . PMID 19465519. doi:10.1152/ajplung.00062.2009. (原始内容存档于2024-06-03).